HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Synthesis and anti-BVDV activity of novel δ-sultones in vitro: implications for HCV therapies.

Abstract
In this study we report the synthesis and activity against bovine viral diarrhea virus (BVDV) of a novel series of bicycle δ-sultones containing γ-lactones. BVDV is responsible for major losses in cattle. Some of the synthesized δ-sultones showed pronounced anti-BVDV activity with EC50 values of 0.12-1.0μM and no significant cytotoxicity. Among them, the ortho bromosubstituted derivative 4f (EC50=0.12μM) showed better antiviral activity than other derivatives and was 10 fold more that of than positive control ribavirin (EC50=1.3μM). BVDV is also considered to be a valuable surrogate for the hepatitis C virus (HCV) in antiviral drug studies. The above results provided a novel candidate for the development of anti-HCV agents.
AuthorsHai-Wei Xu, Ling-Jie Zhao, Huan-Fei Liu, Dan Zhao, Jiao Luo, Xiao-Ping Xie, Wen-Sheng Liu, Jia-Xin Zheng, Gui-Fu Dai, Hong-Min Liu, Long-Hua Liu, Yi-Bo Liang
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 24 Issue 10 Pg. 2388-91 (May 15 2014) ISSN: 1464-3405 [Electronic] England
PMID24745970 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Ltd. All rights reserved.
Chemical References
  • Antiviral Agents
Topics
  • Animals
  • Antiviral Agents (chemical synthesis, pharmacology)
  • Cattle
  • Diarrhea Viruses, Bovine Viral (drug effects)
  • Disease Models, Animal
  • Drug Design
  • Hepacivirus (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: